Based on these findings, network pharmacology analysis revealed that DG targeted multiple ARDS-related core proteins (EGFR, MAPK1, FGFR1) enriched in key signaling pathways such as PI3K-AKT, EGFR, and HIF-1. This evidence concerns the gene AKT1 and acute respiratory distress syndrome.